{"classes":[{"categories":[{"measurements":[{"comment":"The upper bound for the confidence interval has not been attained.","groupId":"OG000","lowerLimit":"9.6","upperLimit":"NA","value":"37.5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"47"}],"units":"Participants"}],"description":"PFS was defined as the time from registration to progression or death due to any cause.\n\nProgression is defined the same as outcome measure #3.","dispersionType":"95% Confidence Interval","groups":[{"id":"OG000","title":"Anakinra With/Without Dexamethasone"}],"paramType":"MEDIAN","populationDescription":"PFS results were published in Mayo Clin Proc, Feb 2009. 47 patients were analyzed for this publication.","reportingStatus":"POSTED","timeFrame":"Time from registration to progression or death (up to 5 years)","title":"Progression Free Survival (PFS) in Patients Treated With Anakinra Alone or in Combination With Dexamethasone","type":"SECONDARY","unitOfMeasure":"months"}